NCC AB (publ) (STO:NCC.A)
188.00
-1.00 (-0.53%)
Aug 1, 2025, 5:21 PM CET
Verve Therapeutics Market Cap
NCC AB has a market cap or net worth of 18.01 billion as of August 1, 2025. Its market cap has increased by 13.60% in one year.
Market Cap
18.01B
Enterprise Value
21.21B
Revenue
60.22B
Ranking
n/a
PE Ratio
11.83
Stock Price
$188.00
Market Cap Chart
Since March 10, 1997, NCC AB's market cap has increased from 7.62B to 18.01B, an increase of 136.29%. That is a compound annual growth rate of 3.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 18.01B | 13.43% |
Dec 30, 2024 | 15.88B | 29.40% |
Dec 29, 2023 | 12.27B | 27.34% |
Dec 30, 2022 | 9.64B | -46.57% |
Dec 30, 2021 | 18.03B | 11.71% |
Dec 30, 2020 | 16.14B | -2.44% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Atlas Copco AB | 681.89B |
AB Volvo | 555.43B |
ASSA ABLOY AB | 354.00B |
Sandvik AB | 292.65B |
Saab AB | 282.38B |
Epiroc AB | 228.23B |
Alfa Laval AB | 172.81B |
Investment AB Latour | 156.76B |